Show simple item record

dc.contributor.authorFord, John A
dc.contributor.authorJones, Rob
dc.contributor.authorElders, Andrew
dc.contributor.authorMulatero, Clive
dc.contributor.authorRoyle, Pamela
dc.contributor.authorSharma, Pawana
dc.contributor.authorStewart, Fiona
dc.contributor.authorTodd, Radha
dc.contributor.authorMowatt, Graham
dc.date.accessioned2013-03-19T12:42:00Z
dc.date.available2013-03-19T12:42:00Z
dc.date.issued2013-01
dc.identifier21627016
dc.identifier9f942f55-cb3f-4fee-9c7a-1b67431de50f
dc.identifier22906748
dc.identifier84872120400
dc.identifier.citationFord , J A , Jones , R , Elders , A , Mulatero , C , Royle , P , Sharma , P , Stewart , F , Todd , R & Mowatt , G 2013 , ' Denosumab for treatment of bone metastases secondary to solid tumours : systematic review and network meta-analysis ' , European Journal of Cancer , vol. 49 , no. 2 , pp. 416-430 . https://doi.org/10.1016/j.ejca.2012.07.016en
dc.identifier.issn1879-0852
dc.identifier.urihttp://hdl.handle.net/2164/2725
dc.descriptionCrown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.en
dc.format.extent15
dc.format.extent475831
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Canceren
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectdenosumaben
dc.subjectzoledronic aciden
dc.subjectpamidronateen
dc.subjectneoplasm metastasisen
dc.subjectindirect estimation techniquesen
dc.subjectR Medicineen
dc.subjectChief Scientist Office (CSO)en
dc.subjectCSO--HSRU1en
dc.subject.lccRen
dc.titleDenosumab for treatment of bone metastases secondary to solid tumours : systematic review and network meta-analysisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1016/j.ejca.2012.07.016


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record